About Dan

This author has not yet filled in any details.
So far Dan has created 9 blog entries.

SmartPharm Therapeutics Appoints John T. Potts, MD, DSc, to Board of Directors

CAMBRIDGE, Mass., Oct. 21, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced the appointment of John T. Potts, MD, DSc, to its Board of Directors. Dr. Potts' distinguished, five-decade career in healthcare and the life sciences spans medical [...]

By |2019-10-21T13:37:57-04:00October 21st, 2019|Press Releases|0 Comments

SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum

SmartPharm Therapeutics Announces Presentation at the 2019 BIO Investor Forum CAMBRIDGE, Mass., Oct. 16, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, Chief Executive Officer, will present at the 2019 BIO [...]

By |2019-11-01T14:23:12-04:00October 16th, 2019|Press Releases|0 Comments

SmartPharm is presenting at Chardan’s 3rd Annual Genetic Medicines Conference

We will be presenting on October 7th at 8:00 AM (ET) at Chardan's 3rd Annual Genetic Medicines Conference. Chardan's annual Genetic Medicines Conference is the largest sell-side conference focused exclusively on advancing the field of genetic medicines. Now in its 3rd year, this expanded one and half day conference brings together executives from more [...]

By |2019-10-04T12:54:48-04:00October 4th, 2019|Events|0 Comments

Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Diseases

We will be at the Oppenheimer Fall Summit Focused on Specialty Pharma and Rare Disease CompaniesCompanies, New York, NY, September 23-24 The summit features one-on-one meetings with a select group companies focused on specialty pharma and orphan and rare disease. Investors will have the opportunity to meet with management teams to discuss in detail [...]

By |2019-10-03T18:42:21-04:00October 3rd, 2019|Events|0 Comments

SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference

SmartPharm Therapeutics Announces Presentation at the Chardan 3rd Annual Genetic Medicines Conference CAMBRIDGE, Mass. – September 30, 2019 – SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, President and Chief Executive Officer, will present [...]

By |2019-09-30T10:32:50-04:00September 30th, 2019|Press Releases|0 Comments

SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors

SmartPharm Therapeutics Appoints Fred Driscoll to Board of Directors Published: Sep 05, 2019 CAMBRIDGE, Mass., Sept. 5, 2019 /PRNewswire/ -- SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced the appointment of Fred Driscoll to its Board of Directors. Mr. [...]

By |2019-09-05T11:15:42-04:00September 5th, 2019|Press Releases|0 Comments

SmartPharm is attending the European Working Group on Gaucher Disease

Join us at the EWGGD We will be at EWGGD 2019 on July 4-6, 2019. Come find us or better yet call and schedule an appointment to meet us!

By |2019-06-25T09:49:53-04:00June 24th, 2019|Events|Comments Off on SmartPharm is attending the European Working Group on Gaucher Disease

SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer

SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer CAMBRIDGE, Mass. – June 25, 2019 – SmartPharm Therapeutics, a pre-clinical stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, today announced that José Trevejo, MD, PhD, has been appointed Chief Executive Officer. Dr. [...]

By |2019-06-28T12:49:33-04:00June 25th, 2018|Press Releases|Comments Off on SmartPharm Therapeutics Appoints José Trevejo, MD, PhD, as Chief Executive Officer